Xbrane Biopharma AB (publ) (STO:XBRANE)

Xbrane Biopharma AB Statistics

Total Valuation

STO:XBRANE has a market cap or net worth of SEK 662.92 million. The enterprise value is 677.05 million.

Market Cap	662.92M
Enterprise Value	677.05M

Important Dates

The last earnings date was Tuesday, August 26, 2025.

Earnings Date	Aug 26, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:XBRANE has 2.55 billion shares outstanding. The number of shares has increased by 220.66% in one year.

Current Share Class	2.55B
Shares Outstanding	2.55B
Shares Change (YoY)	+220.66%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	13.09%
Owned by Institutions (%)	5.78%
Float	2.00B

Valuation Ratios

The trailing PE ratio is 8.34 and the forward PE ratio is 5.21.

PE Ratio	8.34
Forward PE	5.21
PS Ratio	2.49
PB Ratio	1.72
P/TBV Ratio	1.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	8.52
EV / Sales	2.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.78

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.05.

Current Ratio	1.69
Quick Ratio	0.15
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	-3.30

Financial Efficiency

Return on equity (ROE) is -47.45% and return on invested capital (ROIC) is -14.42%.

Return on Equity (ROE)	-47.45%
Return on Assets (ROA)	-8.80%
Return on Invested Capital (ROIC)	-14.42%
Return on Capital Employed (ROCE)	-26.32%
Revenue Per Employee	10.22M
Profits Per Employee	3.06M
Employee Count	65
Asset Turnover	0.37
Inventory Turnover	0.31

Taxes

In the past 12 months, STO:XBRANE has paid 13.82 million in taxes.

Income Tax	13.82M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +97.27% in the last 52 weeks. The beta is 0.74, so STO:XBRANE's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+97.27%
50-Day Moving Average	0.27
200-Day Moving Average	0.21
Relative Strength Index (RSI)	41.77
Average Volume (20 Days)	14,233,084

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:XBRANE had revenue of SEK 265.77 million and earned 79.44 million in profits. Earnings per share was 0.05.

Revenue	265.77M
Gross Profit	198.61M
Operating Income	-101.32M
Pretax Income	-149.76M
Net Income	79.44M
EBITDA	-93.13M
EBIT	-101.32M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 5.86 million in cash and 20.00 million in debt, giving a net cash position of -14.14 million or -0.01 per share.

Cash & Cash Equivalents	5.86M
Total Debt	20.00M
Net Cash	-14.14M
Net Cash Per Share	-0.01
Equity (Book Value)	384.89M
Book Value Per Share	0.25
Working Capital	149.53M

Cash Flow

In the last 12 months, operating cash flow was -54.69 million and capital expenditures -62.40 million, giving a free cash flow of -117.09 million.

Operating Cash Flow	-54.69M
Capital Expenditures	-62.40M
Free Cash Flow	-117.09M
FCF Per Share	-0.05

Margins

Gross margin is 74.73%, with operating and profit margins of -38.12% and 29.89%.

Gross Margin	74.73%
Operating Margin	-38.12%
Pretax Margin	-56.35%
Profit Margin	29.89%
EBITDA Margin	-35.04%
EBIT Margin	-38.12%
FCF Margin	n/a

Dividends & Yields

STO:XBRANE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-220.66%
Shareholder Yield	n/a
Earnings Yield	11.98%
FCF Yield	-17.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:XBRANE has an Altman Z-Score of -2.17 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.17
Piotroski F-Score	4